Global Statistics

All countries
176,909,542
Confirmed
Updated on June 14, 2021 3:47 pm
All countries
159,333,416
Recovered
Updated on June 14, 2021 3:47 pm
All countries
3,822,704
Deaths
Updated on June 14, 2021 3:47 pm
Monday, June 14, 2021

Global Statistics

All countries
176,909,542
Confirmed
Updated on June 14, 2021 3:47 pm
All countries
159,333,416
Recovered
Updated on June 14, 2021 3:47 pm
All countries
3,822,704
Deaths
Updated on June 14, 2021 3:47 pm
Molderizer and Safe Shield

CytoDyn forms supply and distribution deal with Indian firm for leronlimb as coronavirus treatment

Coronavirus global death toll update

The novel coronavirus has killed at least 3,805,928 people since the outbreak emerged in China in December 2019, according to a tally from...

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

Jun 14, 2021 at 6:00 AM93% efficacy against predominantly circulating Variants of Concern and Variants of Interest91% efficacy in high-risk populations100% efficacy against...

US Set To Reach 100 Million Vaccine Shots, But COVID-19 Cases Are Growing | TODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and...

As US COVID-19 Death Toll Nears 600,000, Racial Gaps Persist | Chicago News

In this April 22, 2020, file photo, pallbearers, who were among only 10 allowed mourners, walk the casket for internment at the funeral...

Communication technology, study of collective behavior must be ‘crisis discipline,’ researchers argue

News releases June 14, 2021 Our ability to confront global crises,...


CytoDyn Inc () CEO Nader Pourhassan and Chief Medical Officer and Chairman of the Board Dr. Scott Kelly tells Proactive the late-stage biotechnology company developing leronlimab (Vyrologix or PRO 140) for multiple therapeutic indications, has executed an exclusive supply and distribution agreement with Macleods Pharmaceuticals Ltd in India. 

Pourhassan and Dr. Kelly explain how the commercial agreement will enable Mumbai-based Macleods to sell leronlimab in India as a coronavirus (COVID-19) treatment following regulatory clearance.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash…

FOR OUR FULL DISCLAIMER CLICK HERE



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Coronavirus global death toll update

The novel coronavirus has killed at least 3,805,928 people since the outbreak emerged in China in December 2019, according to a tally from...

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

Jun 14, 2021 at 6:00 AM93% efficacy against predominantly circulating Variants of Concern and Variants of Interest91% efficacy in high-risk populations100% efficacy against...

US Set To Reach 100 Million Vaccine Shots, But COVID-19 Cases Are Growing | TODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and...

Related Articles

Coronavirus global death toll update

The novel coronavirus has killed at least 3,805,928 people since the outbreak emerged in China in December 2019, according to a tally from...

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

Jun 14, 2021 at 6:00 AM93% efficacy against predominantly circulating Variants of Concern and Variants of Interest91% efficacy in high-risk populations100% efficacy against...

US Set To Reach 100 Million Vaccine Shots, But COVID-19 Cases Are Growing | TODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and...